Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or ...
U.S. President Joe Biden on Tuesday proposed expanding coverage of anti-obesity drugs, like Novo Nordisk's Wegovy, for more ...
About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...
With expected sales for GLP1Rs in obesity estimated to surpass $126 billion by 2030, this drug category presents a lucrative ...
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
That increased convenience will have to be accompanied by weight loss that is at least as effective as its rivals, and Amgen ...
A drug used to help Canadians lose weight has now been approved to reduce the risk of non-fatal heart attacks. Novo Nordisk ...
The Biden administration proposed a rule to let Medicare and Medicaid cover obesity drugs like Ozempic. Millions would ...
The Biden administration has announced a new proposal to include weight-loss drugs under Medicare and Medicaid programmes. While the plan will help more than seven million Americans struggling with ...
The Biden administration is proposing that Medicare and Medicaid pay for popular anti-obesity drugs for more Americans.
Concerns have been raised by senior doctors surrounding the misuse of weight-loss pens in the UK, with some patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback